Detailed Information
Cited 3 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Health-related quality of life (HRQoL) in the phase 3 KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) versus placebo plus gem/cis for advanced biliary tract cancer (BTC)
- Authors
- Yoo, C[Yoo, Changhoon]; Finn, RS[Finn, Richard S.]; Mpen, HJKSD[Mpen, Heinz-Josef Klu Spacing Diaeresis]; Kelley, RK[Kelley, Robin Kate]; Vogel, A[Vogel, Arndt]; Furuse, J[Furuse, Junji]; Ren, ZG[Ren, Zhenggang]; Yau, T[Yau, Thomas]; Chan, SL[Chan, Stephen Lam]; Ozaka, M[Ozaka, Masato]; Oh, SC[Oh, Sang Cheul]; Gu, SZ[Gu, Shanzhi]; Park, JO[Park, Joon Oh]; Valle, JW[Valle, Juan W.]; Edeline, J[Edeline, Julien]; Kamble, S[Kamble, Shital]; Norquist, JM[Norquist, Josephine M.]; Yu, L[Yu, Li]; Malhotra, U[Malhotra, Usha]; Ueno, M[Ueno, Makoto]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.